Stratasys Comments on Press Release Issued by 3D Systems
Stratasys Still Waiting for Critical Due Diligence and Regulatory Analysis From 3D Systems MINNEAPOLIS &…
Month: July 2023
KBRA Assigns Preliminary Ratings to BANK 2023-BNK46
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA is pleased to announce the assignment of preliminary ratings to 38 classes…
AIS Earns Eleventh Microsoft Advanced Specialization with AI and Machine Learning, Reinforcing Leadership in Azure OpenAI
RESTON, Va.–(BUSINESS WIRE)–AIS (Applied Information Sciences), experts in helping organizations modernize and innovate with Microsoft…
NetCents Technology Updates Stakeholders on Ongoing Advancements to its Accounting Processes
Vancouver, British Columbia–(Newsfile Corp. – July 28, 2023) – NetCents Technology Inc. (CSE: NC) (FSE:…
Deveron Reports Annual and Special Meeting Results
Toronto, Ontario–(Newsfile Corp. – July 28, 2023) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
KBRA Releases Research — U.S. CRE NPL Securitizations: Poised for a Comeback?
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research that analyzes nonperforming loan (NPL) transactions issued following the global…
Lincoln Financial Group Earns Eighth Consecutive 100% Score on Disability Equality Index
Company recognized as a Best Place to Work for Disability Inclusion RADNOR, Pa.–(BUSINESS WIRE)–Lincoln Financial…
Hitachi Vantara Announces Integrated Solution with Microsoft Azure that Transforms Hybrid Cloud Management
New collaboration reflects companies’ shared commitment to addressing customers’ data complexity and infrastructure modernization challenges…
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
T2 Biosystems to Attend Upcoming Investor Conferences
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
T2 Biosystems to Attend Upcoming Investor Conferences
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Ambrx to Present Preliminary ARX517 First-in-Human Safety, Efficacy, and Pharmacokinetics Data at ESMO 2023
Presentations represent the first time clinical data regarding ARX517 will be presented at a medical…
Ambrx to Present Preliminary ARX517 First-in-Human Safety, Efficacy, and Pharmacokinetics Data at ESMO 2023
Presentations represent the first time clinical data regarding ARX517 will be presented at a medical…
IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa”…
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa”…